Another Major Merger: Schering-Plough to Acquire Organon BioSciences for $14.4 Billion
An another major merger, Schering-Plough is acquiring Organon Biosciences, the animal and human health business of Akzo Nobel for $14.4 Billion.
PharmaLive: Schering-Plough to Acquire Organon BioSciences
Schering think this will be a good addition to their pipeline and the deal is excepted to close before the end of this year. The Organon website is pretty vague on the number and kinds of products in its pipeline so it is hard to judge without further research. They say they have products at various stages including several in pate stage development. They have the plan to fill at least one new major product each year for the next few years. As you can see, it is pretty lacking of details. They do mention two products; asenapine for treatment of bipolar and schizophrenia and sugammadex used to reverse the affects of neuromuscular block
Schering Plough news release:
Schering-Plough to Acquire Organon BioSciences
Other Resources
asenapine - Yahoo! Search Results
asenapine - Google Search
Google Blog Search: asenapine
IceRocket Blog Search: asenapine
sugammadex - Yahoo! Search Results
sugammadex - Google Search
Google Blog Search: sugammadex
IceRocket Blog Search: sugammadex
Technorati Tags: Organon Biosciences, pharma M&A, pharmaceutical deals, Schering-Plough
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
March 26th, 2007 at 11:53 am
Actually, you are incorrect. The Organon website provides quite a bit of information on their
pipeline. http://www.organon.com/innovations/pipeline/index.asp provides a nice overview of all
compounds from pre-clinical through phase III. And you can read about all ongoing clinical trials
at Organon: http://www.organon.com/clinical_trials/Clinical_Trial_Registry/index.asp
March 26th, 2007 at 6:13 pm
Marie, thanks for that link. I sure didn’t find that when I was looking. Also, the old link I had http://www.organonbiosciences.com/index.asp seems now to redirect to http://www.organon.com/authfiles/index.asp. This certainly looks different than when I look for the company website back on March 12th.